A clinical trial to study the effects of two drugs, mundi kshara & yava kshara in patients with cervical ectropion

An open label controlled clinical study to evaluate the effectiveness of Mundi kshara in Cervical ectropion - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055511

Enrollment

Registered

2023-07-21

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N86- Erosion and ectropion of cervix uteri Health Condition 2: N86- Erosion and ectropion of cervix uteri

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed cases of cervical erosion 2. Married female patients between the age group of 21 - 45 years

Exclusion criteria

Exclusion criteria: 1. Pregnant and puerperial women 2. Patients on Oral Contraceptive Pills. 3. Patients on Intra uterine contraceptive devices. 4. Systemic disorders which interfere with the treatment like uncontrolled diabetes mellitus and HIV, HBsAg, VDRL 5. Cervical polyp 6. Cervical carcinoma

Design outcomes

Primary

Measure	Time frame
1. Healing of cervical ectropion according to percentage scale system. 2. Reduction in vaginal dischargeTimepoint: Assessment will be done before treatment, Day 7, after 7days of next menstrual cycle 2. Reduction in vaginal discharge	—

Secondary

Measure	Time frame
Quality of lifeTimepoint: Assessment will be done before treatment, Day 7, after 7days of next menstrual cycle	—

Countries

India

Contacts

Public ContactDr Anjali Suresh Babu

Rajiv Gandhi University of Health Sciences Bengaluru

drshweta@sdmayurbangalore.in9535201172

Outcome results